AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Disruption in Pharma: The Rise of GLP-1 Drugs
This chapter examines the transformative effects of a new class of drugs on the pharmaceutical industry, focusing on the challenges faced by established companies like Eli Lilly. It discusses the manufacturing hurdles, potential health benefits, and the competitive dynamics shaping the future of drug use and wellness.